Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterify is an Italian medical technology company specializing in the development of advanced solutions for infection control and tissue regeneration. The company utilizes a proprietary platform to create bioactive medical devices, including hydrogels and functionalized grafts, designed to prevent surgical site infections and promote healing. Their product portfolio targets diverse clinical areas such as orthopedics, dentistry, and wound care. By integrating antimicrobial properties directly into biomaterials, Sterify aims to improve patient outcomes and reduce the reliance on systemic antibiotics. The company's lead products, Steri-Wash and Steri-Gel, are designed to provide localized protection in surgical and trauma settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterify.